Vivani Medical (VANI) Other Operating Expenses (2014 - 2026)
Vivani Medical (VANI) posted quarterly Other Operating Expenses of $37000.0 for Q1 2026, down 85.49% year-over-year from $255000.0 in Q1 2025, and down 98.84% quarter-over-quarter from $3.2 million in Q4 2025.
Vivani Medical (VANI) Other Operating Expenses (2014 - 2026) Analysis & Trends
Vivani Medical's Other Operating Expenses history runs 12 years deep, the most recent figure standing at $37000.0 for Q1 2026.
- In Q1 2026, Other Operating Expenses fell 85.49% year-over-year to $37000.0; the TTM figure through Mar 2026 stood at $3.7 million (up 332.75% YoY), while the FY2025 annual figure was $8.2 million, up 269.72% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $37000.0, down from $3.2 million in the prior quarter.
- The five-year high for Other Operating Expenses was $6.9 million in Q3 2022, with the low at -$17000.0 in Q1 2022.
- The 5-year median for Other Operating Expenses is $268000.0 (2024), against an average of $789882.4.
- Peak annual rise in Other Operating Expenses reached 114550.0% in 2022, while the deepest fall reached 900.0% in 2022.
- Vivani Medical's Other Operating Expenses stood at $506000.0 in 2022, then plunged by 62.25% to $191000.0 in 2023, then slumped by 93.19% to $13000.0 in 2024, then surged by 24330.77% to $3.2 million in 2025, then slumped by 98.84% to $37000.0 in 2026.
- Business Quant data shows VANI's Other Operating Expenses at $37000.0 in Q1 2026, $3.2 million in Q4 2025, and $195000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 504,000.00 |
| Mar 31, 2026 | 37,000.00 |
| Dec 31, 2025 | 3.18 Mn |
| Sep 30, 2025 | 195,000.00 |
| Jun 30, 2025 | 318,000.00 |
| Mar 31, 2025 | 255,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Jun 30, 2024 | 325,000.00 |
| Mar 31, 2024 | 188,000.00 |
| Dec 31, 2023 | 191,000.00 |
| Sep 30, 2023 | 362,000.00 |
| Jun 30, 2023 | 477,000.00 |
| Mar 31, 2023 | 283,000.00 |
| Dec 31, 2022 | 506,000.00 |
| Sep 30, 2022 | 6.87 Mn |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | -17,000.00 |
| Sep 30, 2021 | -6,000.00 |
| Jun 30, 2021 | 2,000.00 |